Latest News and Press Releases
Want to stay updated on the latest news?
-
Solid Q2 execution: Revenue came in above the midpoint of our guidance despite macro volatility as we continued to expand customer wallet share and drive take rate increase. We also delivered strong...
-
PHILADELPHIA, July 02, 2024 (GLOBE NEWSWIRE) -- Endeavor Venture Funds and Keiretsu Forum Mid-Atlantic, South-East, and Texas announce a key strategic alliance aimed at increasing investment...
-
Novonesis is performing very well and the 2024 outlook for pro forma organic sales growth is now expected at the upper end of the 5-7% range while the pro forma adjusted EBITDA margin is increased to...
-
NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- The National Minority Supplier Development Council (NMSDC) and Founders First Capital Partners are partnering to develop a series of on-demand video...
-
Allentown, Pa, May 16, 2024 (GLOBE NEWSWIRE) -- Content streaming and meal delivery services aren’t the only ones taking advantage of the subscription business model. Starting in the second quarter,...
-
In 2023, Keiretsu Forum MA-SE-TX region’s curated investment portfolio maintained a confident stance within an otherwise retreating investment ecosystem.
-
Fundbox, the leading embedded working capital platform for small businesses, announces Ram Muthaiyan as new Chief Risk & Product Officer.
-
LONDON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (Genflow or the "Company”) (LSE:GENF) (OTCQB:GENFF), an emerging leader in the field of longevity research developing therapeutics...
-
Genflow Biosciences Plc ("Genflow" or "the Company") LONDON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The Company (LSE:GENF) (OTCQB:GENFF), an emerging leader in the field of longevity research...
-
LONDON, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (Genflow or the "Company”) (LSE:GNF) (OTCQB:GENFF), an emerging leader in the field of longevity research developing therapeutics...